CCN3 antibody

Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
CCN3 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab05801
tested applications
ELISA, WB, IHC

Description

Immediate-early protein playing a role in various cellular processes including proliferation, adhesion, migration, differentiation and survival(PubMed:15181016, PubMed:15611078, PubMed:12695522, PubMed:21344378, PubMed:12050162). Acts by binding to integrins or membrane receptors such as NOTCH1(PubMed:12695522, PubMed:21344378, PubMed:15611078). Essential regulator of hematopoietic stem and progenitor cell function(PubMed:17463287). Inhibits myogenic differentiation through the activation of Notch-signaling pathway(PubMed:12050162). Inhibits vascular smooth muscle cells proliferation by increasing expression of cell-cycle regulators such as CDKN2B or CDKN1A independently of TGFB1 signaling(PubMed:20139355). Ligand of integrins ITGAV:ITGB3 and ITGA5:ITGB1, acts directly upon endothelial cells to stimulate pro-angiogenic activities and induces angiogenesis. In endothelial cells, supports cell adhesion, induces directed cell migration(chemotaxis) and promotes cell survival(PubMed:12695522). Plays also a role in cutaneous wound healing acting as integrin receptor ligand. Supports skin fibroblast adhesion through ITGA5:ITGB1 and ITGA6:ITGB1 and induces fibroblast chemotaxis through ITGAV:ITGB5. Seems to enhance bFGF-induced DNA synthesis in fibroblasts(PubMed:15611078). Involved in bone regeneration as a negative regulator(By similarity). Enhances the articular chondrocytic phenotype, whereas it repressed the one representing endochondral ossification(PubMed:21871891). Impairs pancreatic beta-cell function, inhibits beta-cell proliferation and insulin secretion(By similarity). Plays a role as negative regulator of endothelial pro-inflammatory activation reducing monocyte adhesion, its anti-inflammatory effects occur secondary to the inhibition of NF-kappaB signaling pathway(PubMed:21063504). Contributes to the control and coordination of inflammatory processes in atherosclerosis(By similarity). Attenuates inflammatory pain through regulation of IL1B-and TNF-induced MMP9, MMP2 and CCL2 expression. Inhibits MMP9 expression through ITGB1 engagement(PubMed:21871891).

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
nephroblastoma overexpressed gene (CCN3)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1:500-1:2000; IHC: 1:20-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
45kd
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IHC
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
P48745
Gene ID
4856
Alias
CCN family member 3,Cellular communication network factor 3,Insulin-like growth factor-binding protein 9 (IBP-9, IGF-binding protein 9, IGFBP-9),Nephro blastoma-overexpressed gene protein homolog,Protein NOV homolog (NovH),CCN3,IGFBP9,NOV,NOVH
Background
Antibody anti-CCN3
Status
RUO
Note
Mol. Weight 45 kDa

Descripción

Related Products

FNab05801

CCN3 antibody

Immediate-early protein playing a role in various cellular processes including proliferation, adhesion, migration, differentiation and survival(PubMed:15181016, PubMed:15611078, PubMed:12695522, PubMed:21344378, PubMed:12050162). Acts by binding to integrins or membrane receptors such as NOTCH1(PubMed:12695522, PubMed:21344378, PubMed:15611078). Essential regulator of hematopoietic stem and progenitor cell function(PubMed:17463287). Inhibits myogenic differentiation through the activation of Notch-signaling pathway(PubMed:12050162). Inhibits vascular smooth muscle cells proliferation by increasing expression of cell-cycle regulators such as CDKN2B or CDKN1A independently of TGFB1 signaling(PubMed:20139355). Ligand of integrins ITGAV:ITGB3 and ITGA5:ITGB1, acts directly upon endothelial cells to stimulate pro-angiogenic activities and induces angiogenesis. In endothelial cells, supports cell adhesion, induces directed cell migration(chemotaxis) and promotes cell survival(PubMed:12695522). Plays also a role in cutaneous wound healing acting as integrin receptor ligand. Supports skin fibroblast adhesion through ITGA5:ITGB1 and ITGA6:ITGB1 and induces fibroblast chemotaxis through ITGAV:ITGB5. Seems to enhance bFGF-induced DNA synthesis in fibroblasts(PubMed:15611078). Involved in bone regeneration as a negative regulator(By similarity). Enhances the articular chondrocytic phenotype, whereas it repressed the one representing endochondral ossification(PubMed:21871891). Impairs pancreatic beta-cell function, inhibits beta-cell proliferation and insulin secretion(By similarity). Plays a role as negative regulator of endothelial pro-inflammatory activation reducing monocyte adhesion, its anti-inflammatory effects occur secondary to the inhibition of NF-kappaB signaling pathway(PubMed:21063504). Contributes to the control and coordination of inflammatory processes in atherosclerosis(By similarity). Attenuates inflammatory pain through regulation of IL1B-and TNF-induced MMP9, MMP2 and CCL2 expression. Inhibits MMP9 expression through ITGB1 engagement(PubMed:21871891).

Ver Producto
P5254

Recombinant Human CCN3

Ver Producto
abx456368

CCN Family Member 3 (CCN3) Antibody

CCN Family Member 3 (CCN3) Antibody is a Rabbit polyclonal antibody for the detection of Mouse CCN Family Member 3 (CCN3).

Ver Producto